Despite the fact that the settement was a major disappointment, the stock is holding up well, The shorts probably expected a major sell-off so they may start covering in the next few weeks.I'm starting to feel a little more confident
The stock and the company are finished. Any new medical technology for treating cancer will send the stock to a $1.00. The fact that they sold 5 patents related to a hit drug that brings in 100's of millions of dollars in revenue for 5.5 million is a total joke. Was the law firm representing them owned by Celgene? Is Rambotis more concerned about his salary than his company, or our company, the fact that he is extremely overpaid for what he does, what does he do, nobody really knows.
he stock doesn't deserve a higher evaluation. I've owned it for 5 years and it's been the worst return on any capital investment.
$ 5.5 million, what a joke, they should be receiving on paying royalties.
It just goes to show you they don't know what the #$%$#$ they are doing , and they go about hiring the worst of the #$%$ on Wall Street,
If they used a high powered law firm, they would have received tenfold, but instead they hired some firm that was looking to get their cut of a quick deal.
The biggest joke on The Street.